Holders — by stockHoldings — by fund
BRAIDWELL LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001920938
$2.70B
disclosed book value
86
positions
5.4%
largest position share
Positions, as of 2026-06-30
top 86 of 86 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | CAICARIS LIFE SCIENCES INC | 8.3M | $147.1M | 5.4% |
| 2 | HNGEHINGE HEALTH INC | 1.3M | $110.4M | 4.1% |
| 3 | GKOSGLAUKOS CORP | 591,927 | $82.7M | 3.1% |
| 4 | EWTXEDGEWISE THERAPEUTICS INC | 2.0M | $81.1M | 3% |
| 5 | SYRESPYRE THERAPEUTICS INC | 879,467 | $78.1M | 2.9% |
| 6 | IRTCIRHYTHM HOLDINGS INC | 654,262 | $77.8M | 2.9% |
| 7 | NEONEOGENOMICS INC | 4.9M | $71.8M | 2.7% |
| 8 | KODKODIAK SCIENCES INC | 1.8M | $69.6M | 2.6% |
| 9 | XENEXENON PHARMACEUTICALS INC | 1.1M | $68.3M | 2.5% |
| 10 | ATEC 0.75 03/15/30ALPHATEC HLDGS INC | 69.1M | $66.2M | 2.4% |
| 11 | GLUEMONTE ROSA THERAPEUTICS INC | 2.5M | $59.3M | 2.2% |
| 12 | DNTHDIANTHUS THERAPEUTICS INC | 594,562 | $58.0M | 2.1% |
| 13 | NBIXNEUROCRINE BIOSCIENCES INC | 336,171 | $56.7M | 2.1% |
| 14 | ATECALPHATEC HLDGS INC | 6.5M | $56.5M | 2.1% |
| 15 | GENBGENERATE BIOMEDICINES INC | 3.3M | $55.4M | 2% |
| 16 | MRVIMARAVAI LIFESCIENCES HLDGS I | 8.7M | $54.3M | 2% |
| 17 | KRYSKRYSTAL BIOTECH INC | 128,975 | $47.9M | 1.8% |
| 18 | HUMHUMANA INC | 114,500 | $45.5M | 1.7% |
| 19 | TMOTHERMO FISHER SCIENTIFIC INC | 89,395 | $44.8M | 1.7% |
| 20 | KYMRKYMERA THERAPEUTICS INC | 378,163 | $43.4M | 1.6% |
| 21 | RYTMRHYTHM PHARMACEUTICALS INC | 381,128 | $42.3M | 1.6% |
| 22 | DMRADAMORA THERAPEUTICS INC | 1.6M | $42.1M | 1.6% |
| 23 | ACADACADIA PHARMACEUTICALS INC | 1.6M | $41.7M | 1.5% |
| 24 | BTSGBRIGHTSPRING HEALTH SVCS INC | 596,753 | $41.6M | 1.5% |
| 25 | TMDXTRANSMEDICS GROUP INC | 609,715 | $40.5M | 1.5% |
| 26 | MBXMBX BIOSCIENCES INC | 710,880 | $39.2M | 1.5% |
| 27 | CLYMCLIMB BIO INC | 2.8M | $36.5M | 1.3% |
| 28 | CDNACAREDX INC | 1.2M | $34.8M | 1.3% |
| 29 | MAZEMAZE THERAPEUTICS INC | 1.1M | $34.0M | 1.3% |
| 30 | DRUGBRIGHT MINDS BIOSCIENCES INC | 483,822 | $34.0M | 1.3% |
| 31 | ACHCACADIA HEALTHCARE COMPANY IN | 1.1M | $33.7M | 1.2% |
| 32 | NKTRNEKTAR THERAPEUTICS | 473,617 | $33.1M | 1.2% |
| 33 | CRVSCORVUS PHARMACEUTICALS INC | 2.1M | $31.8M | 1.2% |
| 34 | NRIXNURIX THERAPEUTICS INC | 1.3M | $31.2M | 1.2% |
| 35 | INSPINSPIRE MED SYS INC | 677,570 | $30.2M | 1.1% |
| 36 | AVTXAVALO THERAPEUTICS INC | 1.6M | $30.1M | 1.1% |
| 37 | ALMRALAMAR BIOSCIENCES INC | 1.1M | $29.4M | 1.1% |
| 38 | DHRDANAHER CORP DEL | 150,627 | $28.7M | 1.1% |
| 39 | ISRGINTUITIVE SURGICAL INC | 70,137 | $27.9M | 1% |
| 40 | ORKAORUKA THERAPEUTICS INC | 278,164 | $26.5M | 1% |
| 41 | AVLNAVALYN PHARMACEUTICALS INC | 801,395 | $26.4M | 1% |
| 42 | AVAHAVEANNA HEALTHCARE HLDGS INC | 3.1M | $26.3M | 1% |
| 43 | BIOABIOAGE LABS INC | 1.0M | $25.3M | 0.9% |
| 44 | BSXBOSTON SCIENTIFIC CORP | 587,567 | $25.1M | 0.9% |
| 45 | VERAVERA THERAPEUTICS INC | 564,724 | $24.2M | 0.9% |
| 46 | RGENREPLIGEN CORP | 177,100 | $24.2M | 0.9% |
| 47 | ZURAZURA BIO LTD | 4.0M | $23.5M | 0.9% |
| 48 | GHGUARDANT HEALTH INC | 147,850 | $22.2M | 0.8% |
| 49 | EOLSEVOLUS INC | 3.2M | $21.9M | 0.8% |
| 50 | NTRANATERA INC | 79,500 | $21.6M | 0.8% |
| 51 | KIDSORTHOPEDIATRICS CORP | 1.1M | $21.1M | 0.8% |
| 52 | ELVELEVANCE HEALTH INC FORMERLY | 53,960 | $20.9M | 0.8% |
| 53 | TECXTECTONIC THERAPEUTIC INC | 596,900 | $20.5M | 0.8% |
| 54 | DYNDYNE THERAPEUTICS INC | 921,598 | $20.5M | 0.8% |
| 55 | NEO 0.25 01/15/28NEOGENOMICS INC | 18.0M | $16.9M | 0.6% |
| 56 | IMCRIMMUNOCORE HLDGS PLC | 521,327 | $16.6M | 0.6% |
| 57 | RGEN 1 12/15/28REPLIGEN CORP | 16.0M | $16.4M | 0.6% |
| 58 | ARGXARGENX SE | 17,707 | $16.4M | 0.6% |
| 59 | CLDXCELLDEX THERAPEUTICS INC NEW | 436,646 | $16.2M | 0.6% |
| 60 | OVIDOVID THERAPEUTICS INC | 5.9M | $15.9M | 0.6% |
| 61 | MNKDMANNKIND CORP | 3.5M | $14.7M | 0.5% |
| 62 | QUREUNIQURE NV | 301,652 | $13.9M | 0.5% |
| 63 | XFORX4 PHARMACEUTICALS INC | 2.9M | $13.6M | 0.5% |
| 64 | ORICORIC PHARMACEUTICALS INC | 1.2M | $13.2M | 0.5% |
| 65 | KNSAKINIKSA PHARMACEUTICALS INTL | 183,822 | $11.8M | 0.4% |
| 66 | OCSOCULIS HOLDING AG | 834,183 | $11.6M | 0.4% |
| 67 | ACRSACLARIS THERAPEUTICS INC | 2.1M | $11.3M | 0.4% |
| 68 | SPTXSEAPORT THERAPEUTICS INC | 500,000 | $10.9M | 0.4% |
| 69 | VORVOR BIOPHARMA INC | 573,104 | $10.6M | 0.4% |
| 70 | SRZNSURROZEN INC | 390,753 | $10.1M | 0.4% |
| 71 | IMUXIMMUNIC INC | 645,010 | $9.9M | 0.4% |
| 72 | HLXCHELIX ACQUISITION CORP III | 900,000 | $9.5M | 0.4% |
| 73 | IONSIONIS PHARMACEUTICALS INC | 116,762 | $9.3M | 0.3% |
| 74 | DGXQUEST DIAGNOSTICS INC | 43,200 | $9.2M | 0.3% |
| 75 | ANLADLAI NORTYE LTD | 795,214 | $9.1M | 0.3% |
| 76 | TENXTENAX THERAPEUTICS INC | 584,412 | $8.5M | 0.3% |
| 77 | KARDKARDIGAN INC | 300,000 | $7.2M | 0.3% |
| 78 | AMANAMANAT ACQUISITION CORP | 700,000 | $7.1M | 0.3% |
| 79 | COAGHEMAB THERAPEUTICS HLDGS INC | 160,000 | $5.9M | 0.2% |
| 80 | GHRSGH RESEARCH PLC | 207,240 | $5.6M | 0.2% |
| 81 | WATWATERS CORP | 14,040 | $5.3M | 0.2% |
| 82 | RACCRESEARCH ALLIANCE CORP III | 400,000 | $4.3M | 0.2% |
| 83 | JATTJATT II ACQUISITION CORP | 250,000 | $2.8M | 0.1% |
| 84 | LUNGPULMONX CORP | 752,541 | $978,303 | 0% |
| 85 | MNLOUSDVYNE THERAPEUTICS INC | 916,077 | $596,091 | 0% |
| 86 | CYCNCYCLERION THERAPEUTICS INC | 156,890 | $531,857 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.